Literature DB >> 12631665

Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis.

H Saito1, Y Fukuda, K Katsuragi, M Tanaka, M Satomi, T Shimoyama, T Saito, T Tachikawa.   

Abstract

BACKGROUND: Phage displayed random peptide technology has been utilised to identify binding epitopes of antibodies or receptor ligands. AIM: To isolates peptides from a phage library which are specifically recognised by antibodies in serum from patients with Crohn's disease (CD).
METHODS: A phage displayed random peptide library composed of nine amino acids was established and sequentially screened using serum immunogloblin G obtained from CD patients.
RESULTS: Five different CD specific peptides were isolated from the phage library. No homology in amino acid sequences was observed among four (CDP-1, -3 to -5) of the five peptides exhibiting different binding characteristics with each CD patient's serum. In contrast, two peptides (CDP-1 and -2) had similar amino acid sequences and similar binding characteristics. Four multiple antigenic peptides (MAP, CDP-1, -3 to -5) were synthesised, and an enzyme linked immunosorbent assay (ELISA) using the four peptides was developed to detect serum antibodies against them. Fifty two of 92 CD patients (56.5%) were detected by ELISA, none of 20 ulcerative colitis (UC) patients, only one of 25 duodenal ulcer patients, and only three of 48 healthy subjects.
CONCLUSIONS: ELISA using the four peptides isolated in this study may be useful for the differential diagnosis of CD and UC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631665      PMCID: PMC1773613          DOI: 10.1136/gut.52.4.535

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.

Authors:  S Vermeire; S Joossens; M Peeters; F Monsuur; G Marien; X Bossuyt; P Groenen; R Vlietinck; P Rutgeerts
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

2.  Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.

Authors:  F Felici; L Castagnoli; A Musacchio; R Jappelli; G Cesareni
Journal:  J Mol Biol       Date:  1991-11-20       Impact factor: 5.469

3.  Ileoanal reservoir for ulcerative colitis and familial polyposis.

Authors:  D J Schoetz; J A Coller; M C Veidenheimer
Journal:  Arch Surg       Date:  1986-04

4.  Anti-endothelial cell antibodies in inflammatory bowel disease.

Authors:  T R Stevens; S L Harley; J S Groom; G Cambridge; B Leaker; D R Blake; D S Rampton
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

5.  Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis.

Authors:  L S Berberian; Y Valles-Ayoub; L K Gordon; S R Targan; J Braun
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

6.  Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis.

Authors:  F Takahasi; H S Shah; L S Wise; K M Das
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

7.  Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.

Authors:  K Sugi; O Saitoh; R Matsuse; K Tabata; K Uchida; K Kojima; K Nakagawa; S Tanaka; T Teranishi; I Hirata; K Katsu
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

8.  Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.

Authors:  F Seibold; P Weber; H Jenss; K H Wiedmann
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library.

Authors:  A Dybwad; O Førre; J Kjeldsen-Kragh; J B Natvig; M Sioud
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

10.  Long-term results after colectomy and endorectal ileal pullthrough procedure in children.

Authors:  E W Fonkalsrud; N Loar
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

View more
  7 in total

1.  Possible diagnostic role of antibodies to Crohn's disease peptide (ACP): results of a multicenter study in a Japanese cohort.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Junya Masuda; Hiroshi Yamasaki; Kotaro Kuwaki; Hidetoshi Takedatsu; Teppei Kobayashi; Fukunori Kinjo; Kazuto Kishimoto; Toshiyuki Matsui; Fumihito Hirai; Kazuya Makiyama; Kazuo Ohba; Hiroo Abe; Hirohito Tsubouchi; Hiroshi Fujita; Ryuichiro Maekawa; Hiroshi Yoshida; Michio Sata
Journal:  J Gastroenterol       Date:  2013-12-03       Impact factor: 7.527

2.  Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes.

Authors:  John T Ballew; Joseph A Murray; Pekka Collin; Markku Mäki; Martin F Kagnoff; Katri Kaukinen; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

3.  Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease.

Authors:  Moriaki Hatsugai; Manae S Kurokawa; Takefumi Kouro; Kohei Nagai; Mitsumi Arito; Kayo Masuko; Naoya Suematsu; Kazuki Okamoto; Fumio Itoh; Tomohiro Kato
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

4.  Isolation and characterization of a novel short peptide associated with Crohn's disease.

Authors:  K Mitsuyama; M Niwa; J Masuda; K Kuwaki; H Yamasaki; H Takedatsu; T Kobayashi; M Sata
Journal:  Clin Exp Immunol       Date:  2011-07-28       Impact factor: 4.330

5.  Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan.

Authors:  Tatsuki Mizuochi; Katsuhiro Arai; Takahiro Kudo; Ryusuke Nambu; Hitoshi Tajiri; Tomoki Aomatsu; Naoki Abe; Toshihiko Kakiuchi; Kunio Hashimoto; Tsuyoshi Sogo; Michiko Takahashi; Yuri Etani; Yugo Takaki; Ken-Ichiro Konishi; Jun Ishihara; Hitoshi Obara; Tatsuyuki Kakuma; Shunsuke Kurei; Yushiro Yamashita; Keiichi Mitsuyama
Journal:  J Gastroenterol       Date:  2020-01-24       Impact factor: 7.527

Review 6.  Antibody markers in the diagnosis of inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Mikio Niwa; Hidetoshi Takedatsu; Hiroshi Yamasaki; Kotaro Kuwaki; Shinichiro Yoshioka; Ryosuke Yamauchi; Shuhei Fukunaga; Takuji Torimura
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

7.  The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.

Authors:  Yohei Ono; Shuji Kanmura; Yuko Morinaga; Kohei Oda; Katsuto Kawabata; Shiho Arima; Fumisato Sasaki; Yuichirou Nasu; Shiroh Tanoue; Shinichi Hashimoto; Hiroki Taguchi; Hirofumi Uto; Hirohito Tsubouchi; Akio Ido
Journal:  BMC Gastroenterol       Date:  2017-03-11       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.